Source: PR Newswire

Press Release: Sierra Oncology : Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH

- Event featuring renowned myelofibrosis expert Dr. Ruben Mesa scheduled for 7:00 am ET on December 8th - - Data highlighting decreased transfusion requirements for patients treated with momelotinib directly compared to ruxolitinib to be reported in a poster at ASH - VANCOUVER, Dec. 2,...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Stephen Dilly's photo - President & CEO of Sierra

President & CEO

Stephen Dilly

CEO Approval Rating


Sierra is a clinical-stage drug development company that researches, develops and commercializes therapeutics for the treatment of cancer. Read more